ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
PagerDuty, Inc.
14.71
-0.0500
-0.34%
盘后:
14.72
0.0100
+0.07%
18:20 EDT
成交量:
122.03万
成交额:
1,785.19万
市值:
13.56亿
市盈率:
-36.52
高:
14.80
开:
14.69
低:
14.44
收:
14.76
数据加载中...
总览
公司
新闻
公告
加拿大皇家银行:维持PagerDuty评级
智通财经
·
03-15
BUZZ--美国股票走势-华盛顿信托、Centessa Pharma、Kingstone
路透中文
·
03-15
BUZZ-在发布乐观的第四季度业绩和股票回购公告后,PagerDuty 股价上涨
路透中文
·
03-14
美国研究综述-Advanced Flower Capital、BRT Apartments、Xponential Fitness
路透中文
·
03-14
美国研究综述-Advanced Flower Capital、BRT Apartments、Xponential Fitness
路透中文
·
03-14
PagerDuty:2025年Q4财报实现营收1.214亿美元,前值为1.111亿美元
智通财经
·
03-14
PagerDuty Inc 报告截至 1 月 31 日的季度业绩 - 收益摘要
路透中文
·
03-14
PagerDuty 2025 财年第四季度调整后每股收益 $0.22 高于预期 $0.16,销售额 $121.40百万 高于预期 $119.77百万
财报速递
·
03-14
辉瑞(PFE)PD-L1靶向ADC新药在华获批临床
金吾财讯
·
03-11
美国研究综述-Beam Therapeutics、Lennar、Redfin
路透中文
·
03-11
辉瑞(PFE.US)PD-L1靶向ADC新药在华获批临床 拟治疗晚期实体瘤
智通财经
·
03-11
阿斯利康PD-L1在中国获批第4项适应证 AI医疗概念股集体走强丨医药早参
每日经济新闻
·
03-11
阿斯利康(AZN.US)胃癌围手术期PD-L1联合疗法优于标准治疗
智通财经
·
03-07
【康方生物:依沃西头对头帕博利珠单抗Ⅲ期临床研究结果在《柳叶刀》发表】 近日,康方生物自主研发的全球首创PD-1/VEGF双特异性抗体新药依沃西单药对比帕博利珠单抗单药一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌的注册性Ⅲ期临床研究(HARMONi-2/AK112-303)的研究数据,在国际顶级医学期刊《柳叶刀》发表。
金融界
·
03-07
【基石药业-B(02616.HK)在澳大利亚递交CS5001(ROR1 ADC)联合标准治疗用于一线弥漫大B细胞淋巴瘤的临床试验申请】基石药业-B(02616.HK)发布公告,公司已在澳大利亚成功递交CS5001(ROR1 ADC)联合标准治疗用于一线弥漫大B细胞淋巴瘤(DLBCL)的Ib期临床试验申请。此外 CS5001单药及联合PD-L1单抗治疗晚期实体瘤的全球多中心临床试验也在同步开展。
金融界
·
03-06
【百济神州:百泽安在美国获批用于晚期食管鳞状细胞癌联合化疗的一线治疗】3月4日,百济神州宣布,美国食品药品监督管理局已批准百泽安®联合含铂化疗用于肿瘤表达PD-L1的不可切除或转移性食管鳞状细胞癌成人患者一线治疗。百泽安®已在美国获批作为单药用于治疗既往接受过系统化疗后不可切除或转移性ESCC的成人患者,以及联合化疗用于胃和胃食管结合部癌成人患者的一线治疗。
金融界
·
03-05
基石药业PD-1/VEGF/CTLA-4三抗CS2009全球多中心I期临床试验完成首例患者给药
每日经济新闻
·
03-04
【基石药业-B(02616.HK):PD-1/VEGF/CTLA-4三特异性抗体CS2009全球多中心I期临床试验顺利完成首例患者给药】基石药业-B(02616.HK)发布公告,公司自主研发的PD-1/VEGF/CTLA-4三特异性抗体CS2009的全球多中心I期临床试验顺利完成首例患者给药,未发生输液反应或其他不良事件。
金融界
·
03-04
基石药业-B(02616):PD-1/VEGF/CTLA-4三特异性抗体CS2009全球多中心I期临床试验顺利完成首例患者给药
智通财经
·
03-04
头对头帕博利珠单抗,信达生物IBI363(PD-1/IL-2α-bias双特异性抗体融合蛋白)首个关键注册临床研究完成首例受试者给药,用于治疗黑色素瘤
美通社
·
03-03
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/PD/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","market":"US","secType":"STK","nameCN":"PagerDuty, Inc.","latestPrice":14.71,"timestamp":1753387200000,"preClose":14.76,"halted":0,"volume":1220326,"hourTrading":{"tag":"盘后","latestPrice":14.72,"preClose":14.71,"latestTime":"18:20 EDT","volume":29554,"amount":434740.94,"timestamp":1753395635552},"delay":0,"floatShares":82117609,"shares":92173975,"eps":-0.402741,"marketStatus":"未开盘","change":-0.05,"latestTime":"07-24 16:00:00 EDT","open":14.69,"high":14.795,"low":14.44,"amount":17851947.70021,"amplitude":0.024051,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.402741,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753430400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1554955200000,"exchange":"NYSE","adjPreClose":14.76,"preHourTrading":{"tag":"盘前","latestPrice":14.65,"preClose":14.76,"latestTime":"09:28 EDT","volume":2485,"amount":36365.40054,"timestamp":1753363692762},"postHourTrading":{"tag":"盘后","latestPrice":14.72,"preClose":14.71,"latestTime":"18:20 EDT","volume":29554,"amount":434740.94,"timestamp":1753395635552},"volumeRatio":1.293098,"impliedVol":0.4987,"impliedVolPercentile":0.46},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","floatShares":82117609,"roa":"-3.27%","roe":"-19.13%","lyrEps":-0.591956,"volumeRatio":1.293098,"shares":92173975,"dividePrice":0,"high":14.795,"amplitude":0.024051,"preClose":14.76,"low":14.44,"week52Low":13.695,"pbRate":"9.31","psRate":"2.85","week52High":22.02,"institutionHeld":0,"latestPrice":14.71,"eps":-0.402741,"divideRate":0,"volume":1220326,"delay":0,"ttmEps":-0.402741,"open":14.69,"prevYearClose":18.26,"prevWeekClose":14.62,"prevMonthClose":15.28,"prevQuarterClose":15.28,"fiveDayClose":14.65,"twentyDayClose":14.45,"sixtyDayClose":15.7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PD\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519836494","title":"加拿大皇家银行:维持PagerDuty评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2519836494","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519836494?lang=zh_cn&edition=fundamental","pubTime":"2025-03-15 10:49","pubTimestamp":1742006982,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持PagerDuty(PD.US)评级,由优于大市调整至优于大市评级,目标价由24.00美元调整至22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250315105959ab666495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250315105959ab666495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PD"],"gpt_icon":0},{"id":"2519333393","title":"BUZZ--美国股票走势-华盛顿信托、Centessa Pharma、Kingstone","url":"https://stock-news.laohu8.com/highlight/detail?id=2519333393","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519333393?lang=zh_cn&edition=fundamental","pubTime":"2025-03-15 01:49","pubTimestamp":1741974588,"startTime":"0","endTime":"0","summary":"标准普尔 500 指数.PG.INX涨幅前三名是: ** Ulta Beauty Inc ULTA.OQ,上涨 13.0. ** Palantir Technologies Inc PLTR.OQ,上涨 7.7 标普500指数.PL.INX跌幅前三名: ** 雅培实验室ABT.N,下跌 2.8. BUZZ - 在报告 2024 年机器人出租车收入创历史新高后上涨 nL4N3PX0M2 ** Alphabet Inc GOOGL.O:。BUZZ - TD Cowen因谷歌云收入效率问题下调Alphabet的PT值 nL4N3PX0KM ** Crown Castle Inc CCI.N:。BUZZ - 金价触及创纪录的3000美元/盎司关口,金矿商上涨 nL4N3PX0SD ** Charter Communications Inc CHTR.O:。BUZZ - 花旗集团恢复对 Charter Communications 的 \"买入 \"评级 nL4N3PX0SE ** Check Point Software Technologies Ltd CHKP.O:。BUZZ - 在法官裁定重审婴儿配方奶粉案后下跌 nL4N3PX17X ** Integer Holdings Corp ITGR.N:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL4T3PX1EF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4514","SMTC","HBAN","ALAB","LU0157215616.USD","XOM","MACW.SI","PD","KINS","ULTA","CVX","IE000ITXATA3.USD","NEM","RDUS","LU0820562030.AUD","LU1582987324.SGD","LU0061474705.USD","TRUMP.USD.CC","LU0456855351.SGD","GOGO","ABT","CCI","MTB","LU0724618789.USD","AU","SOL","WASH","WAY","CHKP","CVS","LU1914381329.SGD","PB","HRTG","PTCT","PEP","SLB","LU2456880835.USD","CHTR","LU2065171311.SGD","DOCU","RBRK","KEY","ANIP","ITGR","IE00BK4W5M84.HKD","CTRA"],"gpt_icon":1},{"id":"2519980116","title":"BUZZ-在发布乐观的第四季度业绩和股票回购公告后,PagerDuty 股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2519980116","media":"路透中文","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519980116?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 21:02","pubTimestamp":1741957332,"startTime":"0","endTime":"0","summary":"BUZZ-在发布乐观的第四季度业绩和股票回购公告后,PagerDuty 股价上涨3月14日 - ** 软件公司PagerDuty PD.N股价盘前上涨4.7%至16.34美元 * * PD公布第四季度营收为1.214亿美元,高于分析师平均预期的1.198亿美元。** 第四季度每股收益为 22 美分,高于预期的 16 美分。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL4T3PX100:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","LU1169589451.USD","BK4023","PD"],"gpt_icon":0},{"id":"2519484153","title":"美国研究综述-Advanced Flower Capital、BRT Apartments、Xponential Fitness","url":"https://stock-news.laohu8.com/highlight/detail?id=2519484153","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519484153?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 14:44","pubTimestamp":1741934675,"startTime":"0","endTime":"0","summary":"美国研究综述-Advanced Flower Capital、BRT Apartments、Xponential Fitness路透3月14日 - 华尔街证券分析师周五调整了对 Advanced Flower Capital、BRT Apartments 和 Xponential Fitness 等几家美国上市公司的评级和目标价。要点 * Advanced Flower Capital Inc AFCG.O:杰富瑞将其评级从 \"买入 \"下调至 \"持有 * BRT Apartments Corp BRT.N:高力证券将其评级下调至持有 * Xponential Fitness Inc XPOF.N:Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL4T3PX0GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","IE00B64QTZ34.USD","BK4110","LU0323591593.USD","CHE","LU2125154778.USD","XPOF","RBRK","LU1150488135.SGD","LU1989763427.SGD","LU1878469433.USD","DOCU","LU2125154935.USD","LU0985320562.USD","LU0823411888.USD","IE00BLDYK493.USD","LU0266013472.USD","BK4139","BK4200","BK4023","ULTA","LU1169590202.USD","LU0731783394.SGD","LU1430594728.SGD","SG9999001440.SGD","LU1989763690.USD","BK4532","DG","PTCT","BK4215","LU1169589451.USD","BK4216","BK4588","LU1150488218.USD","LU1599440770.SGD","LU1941712264.USD","AFCG","LU0109394709.USD","BK4539","LU1236620834.HKD","LU2108987350.USD","BK4018","BK4533","PD","BK4528","CL","BK4196","BRT","LU2463526074.USD","EVCM"],"gpt_icon":0},{"id":"2519415368","title":"美国研究综述-Advanced Flower Capital、BRT Apartments、Xponential Fitness","url":"https://stock-news.laohu8.com/highlight/detail?id=2519415368","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519415368?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 14:44","pubTimestamp":1741934675,"startTime":"0","endTime":"0","summary":"美国研究综述-Advanced Flower Capital、BRT Apartments、Xponential Fitness路透3月14日 - 华尔街证券分析师周五调整了对 Advanced Flower Capital、BRT Apartments 和 Xponential Fitness 等几家美国上市公司的评级和目标价。要点 * Advanced Flower Capital Inc AFCG.O:杰富瑞将其评级从 \"买入 \"下调至 \"持有 * BRT Apartments Corp BRT.N:高力证券将其评级下调至持有 * Xponential Fitness Inc XPOF.N:Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL4S3PX0GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0731783394.SGD","BRT","LU1878469433.USD","PD","DG","LU1989763427.SGD","BK4613","BK4539","LU1941712264.USD","LU1989763690.USD","PTCT","AFCG","CHE","BK4200","LU0109394709.USD","IE00B64QTZ34.USD","LU0266013472.USD","BK4528","ULTA","LU2463526074.USD","EVCM","DOCU","BK4139","IE00BLDYK493.USD","LU1599440770.SGD","BK4023","LU0323591593.USD","LU0985320562.USD","LU2125154935.USD","XPOF","LU1169590202.USD","LU0823411888.USD","LU1150488135.SGD","BK4533","LU1236620834.HKD","LU2108987350.USD","BK4110","BK4215","BK4216","LU1150488218.USD","LU1169589451.USD","LU2125154778.USD","SG9999001440.SGD","BK4588","BK4532","BK4018","RBRK","BK4196","LU1430594728.SGD","CL"],"gpt_icon":0},{"id":"2519894779","title":"PagerDuty:2025年Q4财报实现营收1.214亿美元,前值为1.111亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2519894779","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519894779?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 08:10","pubTimestamp":1741911033,"startTime":"0","endTime":"0","summary":"PagerDuty(PD.US):2025年Q4财报实现营收1.214亿美元,前值为1.111亿美元,预期值为1.195亿美元;每股收益为0.22美元,前值为0.17美元,预期值为0.16美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314082838ab649ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314082838ab649ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PD"],"gpt_icon":0},{"id":"2519086018","title":"PagerDuty Inc 报告截至 1 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2519086018","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519086018?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 05:57","pubTimestamp":1741903022,"startTime":"0","endTime":"0","summary":"PagerDuty Inc 报告截至 1 月 31 日的季度业绩 - 收益摘要PagerDuty Inc PD.N公布的截至1月31日的季度调整后每股收益为22美分,高于去年同期的每股收益17美分。13位分析师对该季度的平均预期为每股收益16美分。PagerDuty Inc公布的本季度每股收益为亏损12美分。该公司当季亏损 1060 万美元。本季度,PagerDuty Inc 的股价下跌了 11.0%。华尔街对 PagerDuty Inc 的 12 个月目标价中位数为 21.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4S3PW1PJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","PD","LU1169590202.USD","BK4023"],"gpt_icon":0},{"id":"1146565096","title":"PagerDuty 2025 财年第四季度调整后每股收益 $0.22 高于预期 $0.16,销售额 $121.40百万 高于预期 $119.77百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1146565096","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146565096?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 04:10","pubTimestamp":1741896634,"startTime":"0","endTime":"0","summary":"PagerDuty 公布其季度收益为每股 $0.22,较分析师一致预期的 $0.16 高出 37.5%。相比去年同期的每股收益 $0.17,本次数据增长了 29.41%。季度销售额为 $121.40 百万,超出分析师预期的 $119.77 百万,增长率为 1.36%。以上内容来自Benzinga Earnings专栏,原文如下:PagerDuty reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.16 by 37.5 percent. This is a 29.41 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $121.40 million which beat the analyst consensus estimate of $119.77 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PagerDuty 2025 财年第四季度调整后每股收益 $0.22 高于预期 $0.16,销售额 $121.40百万 高于预期 $119.77百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD"],"gpt_icon":0},{"id":"2518797147","title":"辉瑞(PFE)PD-L1靶向ADC新药在华获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797147","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518797147?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 17:07","pubTimestamp":1741684053,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国国家药监局药品审评中心 3月10日公示,辉瑞与Seagen联合开发的1类新药PF-08046054获得临床试验默示许可,拟开展转移性或不可切除晚期实体瘤适应症研究。该药物是辉瑞研发管线中首款靶向PD-L1的抗体偶联药物,具有\"first-in-class\"潜力。PF-08046054采用独特的抗PD-L1抗体-药物偶联设计,由抗PD-L1单抗、可裂解连接子及微管抑制剂MMAE组成。相较于传统PD-1/PD-L1抑制剂,该药物通过结合ADC的双重作用机制,可能为PD-L1表达不足或耐药的实体瘤患者提供新治疗选择。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"286261","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","SG9999001176.USD","LU0058720904.USD","LU1169590202.USD","LU0225771236.USD","LU1066051498.USD","SG9999003800.SGD","LU1883839398.USD","SG9999013999.USD","BK4568","SG9999001176.SGD","BK4585","LU0868494617.USD","BK4592","LU0306806265.USD","LU0985481810.HKD","LU1057294990.SGD","LU1169589451.USD","SG9999002224.SGD","LU0321505868.SGD","LU0122379950.USD","LU1066053197.SGD","BK4231","BK4581","BK4550","SG9999002232.USD","LU1894683264.USD","IE00B19Z3581.USD","BK4007","IE00BLSP4452.SGD","LU0456855351.SGD","IE000M9KFDE8.USD","ADC","BK4080","IE00BBT3K403.USD","LU0289739699.SGD","PD","PFE","BK4588","LU0225284248.USD","LU1894683348.USD","LU0170899867.USD","SGXZ57979304.SGD","BK4534","LU1023059063.AUD","LU0306807586.USD","LU0321505439.SGD","BK4533","IE00BLSP4239.USD","BK4023"],"gpt_icon":1},{"id":"2518761974","title":"美国研究综述-Beam Therapeutics、Lennar、Redfin","url":"https://stock-news.laohu8.com/highlight/detail?id=2518761974","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518761974?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 15:08","pubTimestamp":1741676928,"startTime":"0","endTime":"0","summary":"美国研究综述-Beam Therapeutics、Lennar、Redfin路透3月11日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Beam Therapeutics、Lennar 和 Redfin。要闻 * Beam Therapeutics Inc BEAM.O:Jonestrading将其评级从 \"持有 \"上调至 \"买入\"。* Asana Inc ASAN.N:杰富瑞将目标价从19美元下调至15美元 * Asana Inc ASAN.N:摩根大通将目标价从15美元下调至13美元 * Beam Therapeutics Inc BEAM.O:Jonestrading将其评级从 \"持有 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4S3PU0GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","IE0004445239.USD","SFM","USAC","ASAN","BK4516","LU0323591593.USD","BEAM","LEN","LU0345769631.USD","LU2023250843.SGD","LU1934455194.USD","LU0738911758.USD","LU1429558221.USD","BK4108","BK4187","PD","CDE","LU0965509283.SGD","KGS","LU0820561909.HKD","NOW","LU0965508806.USD","LU0109391861.USD","LU0719512351.SGD","GIS","LU0672654240.SGD","IE00B7SZLL34.SGD","TBRG","BK4581","SER","BK4227","LU2087625088.SGD","LU0353189763.USD","LU0861579265.USD","RDFN","PAY","LU2360106780.USD","BK4556","SARO","IE00BLSP4239.USD","CRBU","LU0985489474.SGD","TKO","VG","BK4596","LU0820561818.USD","LU0056508442.USD","LU2125909759.SGD"],"gpt_icon":1},{"id":"2518980763","title":"辉瑞(PFE.US)PD-L1靶向ADC新药在华获批临床 拟治疗晚期实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2518980763","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518980763?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 14:10","pubTimestamp":1741673430,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月10日,中国国家药监局药品审评中心官网最新公示,辉瑞公司旗下Seagen申报的1类新药PF-08046054获得临床试验默示许可,拟开发治疗转移性或不可切除的晚期实体瘤。公开资料显示,这是辉瑞在研的一款潜在“first-in-class”PD-L1靶向抗体偶联药物。截图来源:CDE官网根据辉瑞公开资料介绍,PF-08046054是一款靶向PD-L1的ADC,由抗PD-L1抗体、连接子和微管破坏剂MMAE组成,可通过直接细胞毒性、旁观者杀伤、免疫原性细胞死亡来发挥抗肿瘤活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","SG9999002232.USD","SG9999011175.SGD","LU0058720904.USD","LU0122379950.USD","BK4599","BK4592","LU0170899867.USD","LU0225284248.USD","LU0306807586.USD","SG9999003800.SGD","LU1169589451.USD","LU1023059063.AUD","IE0002270589.USD","BK4023","PFE","IE00BLSP4452.SGD","SG9999013999.USD","IE00B19Z3581.USD","ADC","LU1057294990.SGD","SG9999002224.SGD","BK4080","BK4581","LU0234572021.USD","BK4550","LU1894683264.USD","LU1894683348.USD","LU0306806265.USD","BK4534","BK4585","LU1169590202.USD","LU0321505439.SGD","SG9999001176.USD","BK4588","BK4533","BK4231","LU0289739699.SGD","LU1066053197.SGD","IE00BBT3K403.USD","LU0985481810.HKD","LU1883839398.USD","SGXZ57979304.SGD","LU1066051498.USD","LU0321505868.SGD","LU0868494617.USD","PD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2518787053","title":"阿斯利康PD-L1在中国获批第4项适应证 AI医疗概念股集体走强丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2518787053","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518787053?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 07:33","pubTimestamp":1741649613,"startTime":"0","endTime":"0","summary":"阿斯利康PD-L1在中国获批第4项适应证 AI医疗概念股集体走强丨医药早参","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503113341709854.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503113341709854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4007","BK4023","LU1169589451.USD","BK4588","BK4585","BK1161","PD","LU1829250122.USD","LU2462157665.USD","LU0320765992.SGD","BK1515","BK4568","LU0889565916.HKD","BK1574","LU2417539215.USD","LU0109394709.USD","AZN","LU1169590202.USD","09939","LU2236285917.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2517438513","title":"阿斯利康(AZN.US)胃癌围手术期PD-L1联合疗法优于标准治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517438513?lang=zh_cn&edition=fundamental","pubTime":"2025-03-07 21:20","pubTimestamp":1741353606,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月7日,阿斯利康宣布III期MATTERHORN研究结果显示,Imfinzi联合标准治疗FLOT化疗作为可切除的早期和局部晚期的胃癌和胃食管交界处癌患者围手术期治疗方案,主要终点无事件生存期具有统计学意义和临床意义的改善。MATTERHORN是首个证明免疫疗法联合治疗优于标准治疗的全球随机III期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4023","LU1829250122.USD","LU2236285917.USD","BK4007","LU0320765992.SGD","BK4585","LU2417539215.USD","BK4588","LU0109394709.USD","LU0889565916.HKD","LU1169589451.USD","LU2462157665.USD","BK4568","PD","LU1169590202.USD","LU2456880835.USD","AZN"],"gpt_icon":0},{"id":"2517122840","title":"【康方生物:依沃西头对头帕博利珠单抗Ⅲ期临床研究结果在《柳叶刀》发表】 近日,康方生物自主研发的全球首创PD-1/VEGF双特异性抗体新药依沃西单药对比帕博利珠单抗单药一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌的注册性Ⅲ期临床研究(HARMONi-2/AK112-303)的研究数据,在国际顶级医学期刊《柳叶刀》发表。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517122840","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517122840?lang=zh_cn&edition=fundamental","pubTime":"2025-03-07 13:57","pubTimestamp":1741327045,"startTime":"0","endTime":"0","summary":"近日,康方生物自主研发的全球首创PD-1/VEGF双特异性抗体新药依沃西单药对比帕博利珠单抗单药一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌的注册性Ⅲ期临床研究(HARMONi-2/AK112-303)的研究数据,在国际顶级医学期刊《柳叶刀》发表。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07135748586398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0348783233.USD","LU0417516571.SGD","LU1169589451.USD","IE00B543WZ88.USD","BK1574","IE00BPRC5H50.USD","LU0348784397.USD","LU1720050803.USD","IE00B5MMRT66.SGD","BK4023","09926","LU1794554557.SGD","LU2488822045.USD","BK1161","PD","LU1169590202.USD"],"gpt_icon":0},{"id":"2517497936","title":"【基石药业-B(02616.HK)在澳大利亚递交CS5001(ROR1 ADC)联合标准治疗用于一线弥漫大B细胞淋巴瘤的临床试验申请】基石药业-B(02616.HK)发布公告,公司已在澳大利亚成功递交CS5001(ROR1 ADC)联合标准治疗用于一线弥漫大B细胞淋巴瘤(DLBCL)的Ib期临床试验申请。此外 CS5001单药及联合PD-L1单抗治疗晚期实体瘤的全球多中心临床试验也在同步开展。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517497936","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517497936?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 08:13","pubTimestamp":1741220034,"startTime":"0","endTime":"0","summary":"基石药业-B(02616.HK)发布公告,公司已在澳大利亚成功递交CS5001(ROR1 ADC)联合标准治疗用于一线弥漫大B细胞淋巴瘤(DLBCL)的Ib期临床试验申请。此外 CS5001单药及联合PD-L1单抗治疗晚期实体瘤的全球多中心临床试验也在同步开展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06081348552983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK4023","BK1574","LU1169589451.USD","BK1141","BK1576","LU1169590202.USD","PD","03347","02616","BK4080","BK4231","BK1583","ADC"],"gpt_icon":0},{"id":"2517802379","title":"【百济神州:百泽安在美国获批用于晚期食管鳞状细胞癌联合化疗的一线治疗】3月4日,百济神州宣布,美国食品药品监督管理局已批准百泽安®联合含铂化疗用于肿瘤表达PD-L1的不可切除或转移性食管鳞状细胞癌成人患者一线治疗。百泽安®已在美国获批作为单药用于治疗既往接受过系统化疗后不可切除或转移性ESCC的成人患者,以及联合化疗用于胃和胃食管结合部癌成人患者的一线治疗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517802379","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517802379?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 07:10","pubTimestamp":1741129814,"startTime":"0","endTime":"0","summary":"3月4日,百济神州宣布,美国食品药品监督管理局已批准百泽安®联合含铂化疗用于肿瘤表达PD-L1的不可切除或转移性食管鳞状细胞癌成人患者一线治疗。百泽安®已在美国获批作为单药用于治疗既往接受过系统化疗后不可切除或转移性ESCC的成人患者,以及联合化疗用于胃和胃食管结合部癌成人患者的一线治疗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05071048524623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1588","BK4023","LU1169589451.USD","PD","LU0588546209.SGD","LU0307460666.USD","LU1169590202.USD","ONC","688235","BK1500","BK1583","LU2328871848.SGD","BK4139","BK0239","BK1161","06160","LU1969619763.USD"],"gpt_icon":0},{"id":"2516690737","title":"基石药业PD-1/VEGF/CTLA-4三抗CS2009全球多中心I期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2516690737","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516690737?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 10:43","pubTimestamp":1741056197,"startTime":"0","endTime":"0","summary":"每经AI快讯,基石药业今日宣布,公司自主研发的PD-1/VEGF/CTLA-4三特异性抗体CS2009的全球多中心I期临床试验顺利完成首例患者给药,未发生输液反应或其他不良事件。该试验将深入评估CS2009在多种晚期实体瘤中的临床应用价值,包括非小细胞肺癌、肝癌、胃癌、子宫内膜癌、卵巢癌、肾细胞癌及宫颈癌等,进而推动肿瘤免疫疗法的创新与发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503043335813894.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503043335813894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03347","LU1169590202.USD","LU1169589451.USD","BK1576","BK1583","PD","BK1141","BK4023"],"gpt_icon":0},{"id":"2516984776","title":"【基石药业-B(02616.HK):PD-1/VEGF/CTLA-4三特异性抗体CS2009全球多中心I期临床试验顺利完成首例患者给药】基石药业-B(02616.HK)发布公告,公司自主研发的PD-1/VEGF/CTLA-4三特异性抗体CS2009的全球多中心I期临床试验顺利完成首例患者给药,未发生输液反应或其他不良事件。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516984776","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516984776?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 08:10","pubTimestamp":1741047048,"startTime":"0","endTime":"0","summary":"基石药业-B(02616.HK)发布公告,公司自主研发的PD-1/VEGF/CTLA-4三特异性抗体CS2009的全球多中心I期临床试验顺利完成首例患者给药,未发生输液反应或其他不良事件。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04081048500557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1169589451.USD","BK1576","BK1141","LU1169590202.USD","BK4023","PD","02616","BK1161","BK1574","BK1583","03347"],"gpt_icon":0},{"id":"2516698610","title":"基石药业-B(02616):PD-1/VEGF/CTLA-4三特异性抗体CS2009全球多中心I期临床试验顺利完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2516698610","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516698610?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 08:06","pubTimestamp":1741046794,"startTime":"0","endTime":"0","summary":"智通财经APP讯,基石药业-B 发布公告,公司自主研发的PD-1/VEGF/CTLA-4三特异性抗体CS2009的全球多中心I期临床试验顺利完成首例患者给药,未发生输液反应或其他不良事件。目前,CS2009率先在澳大利亚开展多中心I期临床试验,未来将陆续扩展至中国及美国。据悉,CS2009是一款靶向PD-1、VEGFA及CTLA-4的三特异性分子,作为靶向大瘤种的三特异性抗体,具备同类首创/同类最优潜力。临床前数据显示,CS2009具有明显优于潜在竞品的抗肿瘤活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1574","BK1161","BK1576","BK4023","BK1141","LU1169589451.USD","LU1169590202.USD","BK1583","02616","PD"],"gpt_icon":0},{"id":"2516452525","title":"头对头帕博利珠单抗,信达生物IBI363(PD-1/IL-2α-bias双特异性抗体融合蛋白)首个关键注册临床研究完成首例受试者给药,用于治疗黑色素瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2516452525","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516452525?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 08:00","pubTimestamp":1740960000,"startTime":"0","endTime":"0","summary":"目前,IBI363已开出首个关键注册临床研究,用于治疗未经免疫治疗的粘膜型和肢端型黑色素瘤。另外,IBI363已获美国FDA两项快速通道资格认定,分别用于治疗鳞状非小细胞肺癌和黑色素瘤。截至目前,信达生物患者援助项目已惠及20余万普通患者,药物捐赠总","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4631081_ZH31081_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2328871848.SGD","BK1589","LU1169589451.USD","LU2488822045.USD","01801","IVBIY","BK4023","LU1969619763.USD","PD","BK1583","BK1161","LU1169590202.USD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":138,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-29","symbol":"PD","fiscalQuarterEnding":"2025/04","expectedEps":-0.06,"name":null,"time":"盘后","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-03-13","symbol":"PD","fiscalQuarterEnding":"2025/01","expectedEps":-0.12,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-11-26","symbol":"PD","fiscalQuarterEnding":"2024/10","expectedEps":-0.11,"name":null,"time":"盘后","type":"earning","dateTimestamp":1732597200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2024-09-03","symbol":"PD","fiscalQuarterEnding":"2024/07","expectedEps":-0.12,"name":null,"time":"盘后","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-05-30","symbol":"PD","fiscalQuarterEnding":"2024/04","expectedEps":-0.11,"name":null,"time":"盘后","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0909,"buy":0.3636,"hold":0.4545,"sell":0.0909,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4545,"analysts":11,"updateTime":1738296000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PD","date":"2025-07-23","current":-36.568846,"percent":0.289147,"low":-81.051795,"twenty":-42.149407,"median":-25.045717,"eighty":-20.116377,"high":-13.794086,"avg":-30.228186,"sd":13.252618,"marketCap":1349426994},"quantilePoints":[{"date":"2020-07-31","current":-48.235072,"twenty":-72.530247,"median":-43.175427,"eighty":-37.208604,"marketCap":2398923066},{"date":"2020-08-07","current":-47.238087,"twenty":-72.318638,"median":-43.360924,"eighty":-37.407321,"marketCap":2349339026},{"date":"2020-08-14","current":-46.177802,"twenty":-72.098738,"median":-43.468321,"eighty":-37.467623,"marketCap":2296606793},{"date":"2020-08-21","current":-45.95625,"twenty":-71.69039,"median":-43.550826,"eighty":-37.518859,"marketCap":2285588118},{"date":"2020-08-28","current":-48.583225,"twenty":-71.41486,"median":-43.699242,"eighty":-37.630539,"marketCap":2416238127},{"date":"2020-09-04","current":-38.528058,"twenty":-71.368789,"median":-43.748751,"eighty":-37.658486,"marketCap":1997756875},{"date":"2020-09-11","current":-36.766338,"twenty":-71.24954,"median":-43.637964,"eighty":-37.464273,"marketCap":1906408152},{"date":"2020-09-18","current":-38.03784,"twenty":-70.931543,"median":-43.525964,"eighty":-37.424178,"marketCap":1972338100},{"date":"2020-09-25","current":-40.596165,"twenty":-70.750862,"median":-43.369188,"eighty":-37.464273,"marketCap":2104992334},{"date":"2020-10-02","current":-42.378825,"twenty":-69.760733,"median":-43.304333,"eighty":-37.506887,"marketCap":2197426830},{"date":"2020-10-09","current":-45.308378,"twenty":-68.893466,"median":-43.360924,"eighty":-37.540906,"marketCap":2349330024},{"date":"2020-10-16","current":-46.719472,"twenty":-68.681421,"median":-43.459295,"eighty":-37.566006,"marketCap":2422498055},{"date":"2020-10-23","current":-44.664183,"twenty":-67.026675,"median":-43.550718,"eighty":-37.624584,"marketCap":2315927228},{"date":"2020-10-30","current":-41.565912,"twenty":-65.321463,"median":-43.550772,"eighty":-37.657731,"marketCap":2155275682},{"date":"2020-11-06","current":-46.121291,"twenty":-64.742086,"median":-43.550826,"eighty":-37.676934,"marketCap":2391481172},{"date":"2020-11-13","current":-46.35136,"twenty":-63.787431,"median":-43.643849,"eighty":-37.728931,"marketCap":2403410742},{"date":"2020-11-20","current":-47.79313,"twenty":-62.855819,"median":-43.781756,"eighty":-37.757248,"marketCap":2478169382},{"date":"2020-11-27","current":-52.440537,"twenty":-62.329113,"median":-43.973974,"eighty":-37.811067,"marketCap":2719146700},{"date":"2020-12-04","current":-58.503982,"twenty":-61.897872,"median":-44.116471,"eighty":-37.910083,"marketCap":3346135266},{"date":"2020-12-11","current":-61.956348,"twenty":-61.897872,"median":-44.23472,"eighty":-37.979009,"marketCap":3543593297},{"date":"2020-12-18","current":-64.76408,"twenty":-63.261641,"median":-44.342085,"eighty":-38.134161,"marketCap":3704181571},{"date":"2020-12-24","current":-65.981719,"twenty":-64.468982,"median":-44.366057,"eighty":-38.286785,"marketCap":3773824445},{"date":"2020-12-31","current":-59.735947,"twenty":-64.377301,"median":-44.622066,"eighty":-38.319351,"marketCap":3416597468},{"date":"2021-01-08","current":-63.775644,"twenty":-64.248374,"median":-44.664183,"eighty":-38.342002,"marketCap":3647647944},{"date":"2021-01-15","current":-65.265461,"twenty":-64.491902,"median":-44.85652,"eighty":-38.342002,"marketCap":3732858049},{"date":"2021-01-22","current":-70.007091,"twenty":-64.924465,"median":-44.940871,"eighty":-38.368803,"marketCap":4004055593},{"date":"2021-01-29","current":-69.806539,"twenty":-66.010369,"median":-45.124322,"eighty":-38.447577,"marketCap":3992585002},{"date":"2021-02-05","current":-78.774094,"twenty":-67.606194,"median":-45.279297,"eighty":-38.515566,"marketCap":4505484287},{"date":"2021-02-12","current":-81.051795,"twenty":-68.875403,"median":-45.308378,"eighty":-38.533013,"marketCap":4635757427},{"date":"2021-02-19","current":-74.533844,"twenty":-69.256452,"median":-45.492434,"eighty":-38.599807,"marketCap":4262963219},{"date":"2021-02-26","current":-64.090797,"twenty":-69.256452,"median":-45.616009,"eighty":-38.656949,"marketCap":3665673158},{"date":"2021-03-05","current":-53.862628,"twenty":-69.159583,"median":-45.671397,"eighty":-38.66724,"marketCap":3080673016},{"date":"2021-03-12","current":-60.509506,"twenty":-69.072496,"median":-45.726784,"eighty":-38.673459,"marketCap":3460841176},{"date":"2021-03-19","current":-49.639711,"twenty":-68.918379,"median":-45.797998,"eighty":-38.687063,"marketCap":3420324980},{"date":"2021-03-26","current":-46.372989,"twenty":-68.782324,"median":-45.852876,"eighty":-38.706425,"marketCap":3195238028},{"date":"2021-04-01","current":-49.627656,"twenty":-68.703922,"median":-45.852876,"eighty":-38.74149,"marketCap":3419494401},{"date":"2021-04-09","current":-50.688437,"twenty":-68.634603,"median":-45.95625,"eighty":-38.792193,"marketCap":3492585367},{"date":"2021-04-16","current":-50.965686,"twenty":-68.620415,"median":-46.098464,"eighty":-38.810779,"marketCap":3511688688},{"date":"2021-04-23","current":-50.965686,"twenty":-68.551655,"median":-46.177802,"eighty":-38.849388,"marketCap":3511688688},{"date":"2021-04-30","current":-51.182664,"twenty":-68.073194,"median":-46.296231,"eighty":-38.932876,"marketCap":3526639113},{"date":"2021-05-07","current":-45.52431,"twenty":-67.425697,"median":-46.35136,"eighty":-39.005886,"marketCap":3136761501},{"date":"2021-05-14","current":-42.286432,"twenty":-67.150653,"median":-46.187891,"eighty":-39.046881,"marketCap":2913662055},{"date":"2021-05-21","current":-44.081211,"twenty":-66.824039,"median":-46.121291,"eighty":-39.054259,"marketCap":3037327665},{"date":"2021-05-28","current":-49.295769,"twenty":-66.574781,"median":-46.172553,"eighty":-39.081958,"marketCap":3396626399},{"date":"2021-06-04","current":-36.968776,"twenty":-66.216652,"median":-46.172553,"eighty":-39.072116,"marketCap":2957576028},{"date":"2021-06-11","current":-42.279901,"twenty":-66.096321,"median":-46.075636,"eighty":-39.072116,"marketCap":3382476656},{"date":"2021-06-18","current":-45.709132,"twenty":-65.976077,"median":-45.923735,"eighty":-39.125091,"marketCap":3656821944},{"date":"2021-06-25","current":-47.162372,"twenty":-65.815901,"median":-46.067026,"eighty":-39.183405,"marketCap":3773084124},{"date":"2021-07-02","current":-44.130431,"twenty":-65.216755,"median":-46.011638,"eighty":-39.205083,"marketCap":3530522741},{"date":"2021-07-09","current":-45.834591,"twenty":-65.021933,"median":-45.883552,"eighty":-39.229781,"marketCap":3666858967},{"date":"2021-07-16","current":-40.199362,"twenty":-64.900098,"median":-45.829869,"eighty":-39.313533,"marketCap":3216029363},{"date":"2021-07-23","current":-43.325398,"twenty":-64.76408,"median":-45.766347,"eighty":-39.330284,"marketCap":3466118512},{"date":"2021-07-30","current":-42.436726,"twenty":-64.636745,"median":-45.712576,"eighty":-39.369202,"marketCap":3395022935},{"date":"2021-08-06","current":-44.33953,"twenty":-64.491902,"median":-45.685037,"eighty":-39.631794,"marketCap":3547251112},{"date":"2021-08-13","current":-42.269446,"twenty":-64.377301,"median":-45.655572,"eighty":-39.648544,"marketCap":3381640238},{"date":"2021-08-20","current":-40.387552,"twenty":-64.32,"median":-45.516041,"eighty":-39.732297,"marketCap":3231084897},{"date":"2021-08-27","current":-43.743597,"twenty":-64.248374,"median":-45.492434,"eighty":-39.784241,"marketCap":3499575255},{"date":"2021-09-03","current":-42.390054,"twenty":-64.090797,"median":-45.440934,"eighty":-39.784241,"marketCap":4025995391},{"date":"2021-09-10","current":-39.410762,"twenty":-63.838675,"median":-45.357157,"eighty":-39.773852,"marketCap":3743037083},{"date":"2021-09-17","current":-42.488469,"twenty":-63.43184,"median":-45.291593,"eighty":-39.773852,"marketCap":4035342362},{"date":"2021-09-24","current":-41.531159,"twenty":-63.322968,"median":-45.131991,"eighty":-39.806871,"marketCap":3944421825},{"date":"2021-10-01","current":-37.845067,"twenty":-63.294318,"median":-44.969953,"eighty":-39.673042,"marketCap":3594335269},{"date":"2021-10-08","current":-35.304169,"twenty":-63.234694,"median":-44.895964,"eighty":-39.361418,"marketCap":3353013468},{"date":"2021-10-15","current":-36.968279,"twenty":-62.977151,"median":-44.757709,"eighty":-39.195032,"marketCap":3511062253},{"date":"2021-10-22","current":-37.567716,"twenty":-62.673,"median":-44.689179,"eighty":-39.048237,"marketCap":3567993805},{"date":"2021-10-29","current":-37.352992,"twenty":-62.144822,"median":-44.662724,"eighty":-38.884343,"marketCap":3547600413},{"date":"2021-11-05","current":-38.927633,"twenty":-61.970673,"median":-44.622066,"eighty":-38.780249,"marketCap":3697151952},{"date":"2021-11-12","current":-37.684024,"twenty":-61.914834,"median":-44.517265,"eighty":-38.690435,"marketCap":3579040225},{"date":"2021-11-19","current":-34.892615,"twenty":-61.891288,"median":-44.350719,"eighty":-38.663132,"marketCap":3313926135},{"date":"2021-11-26","current":-33.094304,"twenty":-61.87812,"median":-44.340807,"eighty":-38.647574,"marketCap":3143131480},{"date":"2021-12-03","current":-27.717262,"twenty":-61.851785,"median":-44.310434,"eighty":-38.490518,"marketCap":2632446965},{"date":"2021-12-10","current":-29.437491,"twenty":-61.634212,"median":-44.193031,"eighty":-38.342002,"marketCap":2964590848},{"date":"2021-12-17","current":-29.446029,"twenty":-61.446371,"median":-44.130431,"eighty":-38.122419,"marketCap":2965450648},{"date":"2021-12-23","current":-30.863263,"twenty":-61.141525,"median":-44.120926,"eighty":-37.910083,"marketCap":3108177469},{"date":"2021-12-31","current":-29.668005,"twenty":-60.679678,"median":-44.096614,"eighty":-37.767931,"marketCap":2987805451},{"date":"2022-01-07","current":-27.243339,"twenty":-60.561077,"median":-44.020576,"eighty":-37.685906,"marketCap":2743622214},{"date":"2022-01-14","current":-26.466422,"twenty":-60.402519,"median":-43.931787,"eighty":-37.609143,"marketCap":2665380403},{"date":"2022-01-21","current":-25.715117,"twenty":-60.229637,"median":-43.82863,"eighty":-37.535067,"marketCap":2589717991},{"date":"2022-01-28","current":-27.448241,"twenty":-60.179262,"median":-43.748751,"eighty":-37.457573,"marketCap":2764257417},{"date":"2022-02-04","current":-27.106738,"twenty":-60.125395,"median":-43.643849,"eighty":-37.310047,"marketCap":2729865412},{"date":"2022-02-11","current":-28.728874,"twenty":-59.884929,"median":-43.550718,"eighty":-37.143446,"marketCap":2893227437},{"date":"2022-02-18","current":-27.106738,"twenty":-59.724487,"median":-43.492185,"eighty":-36.968378,"marketCap":2729865412},{"date":"2022-02-25","current":-28.071482,"twenty":-59.678646,"median":-43.437917,"eighty":-36.905651,"marketCap":2827022827},{"date":"2022-03-04","current":-25.322389,"twenty":-59.583656,"median":-43.360924,"eighty":-36.834452,"marketCap":2550167185},{"date":"2022-03-11","current":-22.70136,"twenty":-59.306192,"median":-43.319423,"eighty":-36.766338,"marketCap":2286208545},{"date":"2022-03-18","current":-28.291592,"twenty":-59.172166,"median":-43.295217,"eighty":-36.444632,"marketCap":3040073042},{"date":"2022-03-25","current":-28.785804,"twenty":-59.048339,"median":-43.241759,"eighty":-36.064649,"marketCap":3093178556},{"date":"2022-04-01","current":-27.724464,"twenty":-59.048339,"median":-43.1764,"eighty":-35.678665,"marketCap":2979132288},{"date":"2022-04-08","current":-25.415442,"twenty":-58.958192,"median":-43.086807,"eighty":-35.293402,"marketCap":2731016361},{"date":"2022-04-14","current":-26.428171,"twenty":-58.866018,"median":-43.039133,"eighty":-34.945236,"marketCap":2839839136},{"date":"2022-04-22","current":-23.843687,"twenty":-58.778063,"median":-42.940117,"eighty":-34.48789,"marketCap":2562123414},{"date":"2022-04-29","current":-23.14693,"twenty":-58.704534,"median":-42.888728,"eighty":-33.407653,"marketCap":2487253345},{"date":"2022-05-06","current":-21.039181,"twenty":-58.614907,"median":-42.82356,"eighty":-33.196501,"marketCap":2260765197},{"date":"2022-05-13","current":-21.537198,"twenty":-58.533862,"median":-42.744231,"eighty":-33.138326,"marketCap":2314279623},{"date":"2022-05-20","current":-19.528801,"twenty":-58.506847,"median":-42.67719,"eighty":-32.784627,"marketCap":2098467346},{"date":"2022-05-27","current":-21.055509,"twenty":-58.47232,"median":-42.506172,"eighty":-32.56425,"marketCap":2262519768},{"date":"2022-06-03","current":-19.41561,"twenty":-58.365647,"median":-42.492303,"eighty":-32.253988,"marketCap":2285547362},{"date":"2022-06-10","current":-18.661968,"twenty":-58.119439,"median":-42.449993,"eighty":-31.627913,"marketCap":2196830881},{"date":"2022-06-17","current":-17.871017,"twenty":-57.794408,"median":-42.412967,"eighty":-30.853018,"marketCap":2103722495},{"date":"2022-06-24","current":-21.251213,"twenty":-57.545961,"median":-42.37641,"eighty":-30.527663,"marketCap":2501629088},{"date":"2022-07-01","current":-18.975364,"twenty":-57.27835,"median":-42.328632,"eighty":-30.205871,"marketCap":2233722883},{"date":"2022-07-08","current":-20.758734,"twenty":-57.119373,"median":-42.300639,"eighty":-29.937792,"marketCap":2443655942},{"date":"2022-07-15","current":-19.512613,"twenty":-57.022546,"median":-42.274674,"eighty":-29.686169,"marketCap":2296966315},{"date":"2022-07-22","current":-19.751391,"twenty":-56.538634,"median":-42.258991,"eighty":-29.576542,"marketCap":2325074507},{"date":"2022-07-29","current":-19.348454,"twenty":-55.37095,"median":-42.1379,"eighty":-29.489533,"marketCap":2277641933},{"date":"2022-08-05","current":-21.340755,"twenty":-54.581356,"median":-41.999461,"eighty":-29.249821,"marketCap":2512169660},{"date":"2022-08-12","current":-21.370602,"twenty":-54.282209,"median":-41.907002,"eighty":-28.899625,"marketCap":2515683184},{"date":"2022-08-19","current":-19.214141,"twenty":-54.164004,"median":-41.742363,"eighty":-28.761236,"marketCap":2261831075},{"date":"2022-08-26","current":-19.318607,"twenty":-54.013801,"median":-41.687142,"eighty":-28.490216,"marketCap":2274128409},{"date":"2022-09-02","current":-16.562766,"twenty":-53.825684,"median":-41.612639,"eighty":-28.401837,"marketCap":2096100841},{"date":"2022-09-09","current":-17.753369,"twenty":-53.67791,"median":-41.5952,"eighty":-28.368118,"marketCap":2246777593},{"date":"2022-09-16","current":-16.597991,"twenty":-53.584381,"median":-41.569297,"eighty":-28.257217,"marketCap":2100558733},{"date":"2022-09-23","current":-15.858267,"twenty":-53.533149,"median":-41.530643,"eighty":-28.105632,"marketCap":2006943000},{"date":"2022-09-30","current":-16.252786,"twenty":-53.345477,"median":-41.466004,"eighty":-27.873415,"marketCap":2056871391},{"date":"2022-10-07","current":-16.182337,"twenty":-53.110426,"median":-41.390601,"eighty":-27.717262,"marketCap":2047955607},{"date":"2022-10-14","current":-14.646529,"twenty":-52.79331,"median":-41.34773,"eighty":-27.636067,"marketCap":1853591514},{"date":"2022-10-21","current":-16.485271,"twenty":-52.578578,"median":-41.307589,"eighty":-27.328715,"marketCap":2086293479},{"date":"2022-10-28","current":-17.922449,"twenty":-52.484531,"median":-41.281723,"eighty":-27.012825,"marketCap":2268175475},{"date":"2022-11-04","current":-14.604259,"twenty":-52.445692,"median":-41.223096,"eighty":-26.683037,"marketCap":1848242043},{"date":"2022-11-11","current":-17.35885,"twenty":-52.440537,"median":-41.165581,"eighty":-26.46868,"marketCap":2196849202},{"date":"2022-11-18","current":-15.442613,"twenty":-51.97825,"median":-41.046215,"eighty":-26.415612,"marketCap":1954339874},{"date":"2022-11-25","current":-15.379208,"twenty":-51.971496,"median":-40.952393,"eighty":-26.24103,"marketCap":1946315669},{"date":"2022-12-02","current":-16.042428,"twenty":-51.941247,"median":-40.886211,"eighty":-26.002015,"marketCap":2129728606},{"date":"2022-12-09","current":-16.110204,"twenty":-51.872986,"median":-40.837833,"eighty":-25.713912,"marketCap":2138726192},{"date":"2022-12-16","current":-18.028246,"twenty":-51.7604,"median":-40.772608,"eighty":-25.598799,"marketCap":2393357876},{"date":"2022-12-23","current":-17.994359,"twenty":-51.70784,"median":-40.745253,"eighty":-25.338499,"marketCap":2388859083},{"date":"2022-12-30","current":-18.001136,"twenty":-51.570726,"median":-40.701201,"eighty":-25.184081,"marketCap":2389758841},{"date":"2023-01-06","current":-16.049206,"twenty":-51.363479,"median":-40.623172,"eighty":-24.85486,"marketCap":2130628364},{"date":"2023-01-13","current":-18.78733,"twenty":-51.102161,"median":-40.574619,"eighty":-24.231092,"marketCap":2494130839},{"date":"2023-01-20","current":-18.882216,"twenty":-50.978262,"median":-40.523325,"eighty":-23.99114,"marketCap":2506727459},{"date":"2023-01-27","current":-19.925957,"twenty":-50.965686,"median":-40.469321,"eighty":-23.312385,"marketCap":2645290284},{"date":"2023-02-03","current":-21.220466,"twenty":-50.951221,"median":-40.311267,"eighty":-22.57339,"marketCap":2817144176},{"date":"2023-02-10","current":-19.627745,"twenty":-50.890949,"median":-40.250171,"eighty":-21.596594,"marketCap":2605700905},{"date":"2023-02-17","current":-20.664708,"twenty":-50.876484,"median":-40.190227,"eighty":-21.430411,"marketCap":2743363971},{"date":"2023-02-24","current":-19.485417,"twenty":-50.857197,"median":-40.120759,"eighty":-21.251213,"marketCap":2586805975},{"date":"2023-03-03","current":-20.834146,"twenty":-50.688437,"median":-40.045986,"eighty":-21.055509,"marketCap":2765857936},{"date":"2023-03-10","current":-18.204462,"twenty":-50.646894,"median":-39.953806,"eighty":-20.967665,"marketCap":2416751599},{"date":"2023-03-17","current":-22.814647,"twenty":-50.628165,"median":-39.81605,"eighty":-20.881589,"marketCap":2929925462},{"date":"2023-03-24","current":-22.508745,"twenty":-50.547877,"median":-39.758269,"eighty":-20.937818,"marketCap":2890640524},{"date":"2023-03-31","current":-24.884826,"twenty":-50.538628,"median":-39.648544,"eighty":-20.967665,"marketCap":3195783993},{"date":"2023-04-06","current":-22.608341,"twenty":-50.398102,"median":-39.410762,"eighty":-20.985573,"marketCap":2903430969},{"date":"2023-04-14","current":-23.753697,"twenty":-50.260054,"median":-39.321908,"eighty":-21.029355,"marketCap":3050521084},{"date":"2023-04-21","current":-24.273021,"twenty":-50.211876,"median":-39.198908,"eighty":-21.041663,"marketCap":3117214118},{"date":"2023-04-28","current":-22.053448,"twenty":-50.10983,"median":-39.086878,"eighty":-21.052864,"marketCap":2832169920},{"date":"2023-05-05","current":-20.085339,"twenty":-50.030853,"median":-39.045525,"eighty":-21.029355,"marketCap":2579419472},{"date":"2023-05-12","current":-21.254175,"twenty":-50.011348,"median":-38.97946,"eighty":-20.981096,"marketCap":2729524925},{"date":"2023-05-19","current":-21.074906,"twenty":-49.936988,"median":-38.858126,"eighty":-20.935287,"marketCap":2706502616},{"date":"2023-05-26","current":-18.98821,"twenty":-49.739821,"median":-38.781427,"eighty":-20.865452,"marketCap":2438522942},{"date":"2023-06-02","current":-23.7011,"twenty":-49.634889,"median":-38.748697,"eighty":-20.83367,"marketCap":2555476271},{"date":"2023-06-09","current":-19.16437,"twenty":-49.587066,"median":-38.685442,"eighty":-20.780404,"marketCap":2066321490},{"date":"2023-06-16","current":-19.591955,"twenty":-49.518553,"median":-38.668128,"eighty":-20.758997,"marketCap":2112424156},{"date":"2023-06-23","current":-18.642716,"twenty":-49.490829,"median":-38.652026,"eighty":-20.740419,"marketCap":2010076237},{"date":"2023-06-30","current":-18.830853,"twenty":-49.425691,"median":-38.650282,"eighty":-20.728887,"marketCap":2030361410},{"date":"2023-07-07","current":-18.753888,"twenty":-49.321753,"median":-38.534252,"eighty":-20.640309,"marketCap":2022062930},{"date":"2023-07-14","current":-21.12271,"twenty":-49.135663,"median":-38.486364,"eighty":-20.586625,"marketCap":2277471700},{"date":"2023-07-21","current":-20.626711,"twenty":-49.077653,"median":-38.375503,"eighty":-20.595005,"marketCap":2223992607},{"date":"2023-07-28","current":-21.105606,"twenty":-49.061015,"median":-38.330676,"eighty":-20.595005,"marketCap":2275627593},{"date":"2023-08-04","current":-20.883262,"twenty":-49.007339,"median":-38.158206,"eighty":-20.613914,"marketCap":2251654207},{"date":"2023-08-11","current":-20.549746,"twenty":-48.954208,"median":-37.988814,"eighty":-20.586625,"marketCap":2215694127},{"date":"2023-08-18","current":-20.01954,"twenty":-48.941266,"median":-37.845067,"eighty":-20.541194,"marketCap":2158526822},{"date":"2023-08-25","current":-20.66947,"twenty":-48.894876,"median":-37.770349,"eighty":-20.506987,"marketCap":2228602874},{"date":"2023-09-01","current":-25.511357,"twenty":-48.832826,"median":-37.755599,"eighty":-20.541194,"marketCap":2375209352},{"date":"2023-09-07","current":-24.043412,"twenty":-48.807682,"median":-37.686377,"eighty":-20.560008,"marketCap":2238537799},{"date":"2023-09-14","current":-23.412009,"twenty":-48.750972,"median":-37.671633,"eighty":-20.577111,"marketCap":2179751687},{"date":"2023-09-22","current":-22.590183,"twenty":-48.595885,"median":-37.578261,"eighty":-20.58462,"marketCap":2103236431},{"date":"2023-09-28","current":-22.048981,"twenty":-48.583225,"median":-37.547623,"eighty":-20.587293,"marketCap":2052848336},{"date":"2023-10-05","current":-21.978825,"twenty":-48.576545,"median":-37.531928,"eighty":-20.595005,"marketCap":2046316545},{"date":"2023-10-11","current":-21.497757,"twenty":-48.562801,"median":-37.500901,"eighty":-20.605423,"marketCap":2001527127},{"date":"2023-10-20","current":-20.345196,"twenty":-48.534663,"median":-37.448341,"eighty":-20.589221,"marketCap":1894219146},{"date":"2023-10-27","current":-19.894194,"twenty":-48.514606,"median":-37.410785,"eighty":-20.580532,"marketCap":1852229066},{"date":"2023-11-03","current":-20.485508,"twenty":-48.433814,"median":-37.299311,"eighty":-20.506205,"marketCap":1907282726},{"date":"2023-11-10","current":-20.746087,"twenty":-48.370598,"median":-37.219715,"eighty":-20.506987,"marketCap":1931543661},{"date":"2023-11-17","current":-21.217133,"twenty":-48.32991,"median":-37.120374,"eighty":-20.524091,"marketCap":1975399966},{"date":"2023-11-24","current":-21.858558,"twenty":-48.320008,"median":-37.057747,"eighty":-20.549746,"marketCap":2035119191},{"date":"2023-11-30","current":-22.048981,"twenty":-48.252059,"median":-36.968279,"eighty":-20.57027,"marketCap":2052848336},{"date":"2023-12-07","current":-26.625426,"twenty":-48.121131,"median":-36.925787,"eighty":-20.578821,"marketCap":2015198621},{"date":"2023-12-15","current":-28.276615,"twenty":-48.00719,"median":-36.911135,"eighty":-20.582242,"marketCap":2140172179},{"date":"2024-01-05","current":-26.103359,"twenty":-47.918569,"median":-36.904212,"eighty":-20.585288,"marketCap":1975684923},{"date":"2024-01-12","current":-31.117632,"twenty":-47.865829,"median":-36.842529,"eighty":-20.591149,"marketCap":2355200212},{"date":"2024-01-19","current":-31.627558,"twenty":-47.844972,"median":-36.829603,"eighty":-20.601178,"marketCap":2393794988},{"date":"2024-01-26","current":-29.053645,"twenty":-47.78321,"median":-36.766338,"eighty":-20.619869,"marketCap":2198983265},{"date":"2024-02-02","current":-29.32075,"twenty":-47.731847,"median":-36.504107,"eighty":-20.628421,"marketCap":2219199576},{"date":"2024-02-09","current":-29.393596,"twenty":-47.672575,"median":-36.388531,"eighty":-20.635263,"marketCap":2224713115},{"date":"2024-02-16","current":-29.733547,"twenty":-47.618326,"median":-36.095963,"eighty":-20.635379,"marketCap":2250442965},{"date":"2024-02-23","current":-28.10664,"twenty":-47.602066,"median":-35.89466,"eighty":-20.635842,"marketCap":2127307254},{"date":"2024-03-01","current":-29.332891,"twenty":-47.570415,"median":-35.678665,"eighty":-20.651153,"marketCap":2220118499},{"date":"2024-03-08","current":-29.55143,"twenty":-47.518149,"median":-35.35785,"eighty":-20.660918,"marketCap":2236659117},{"date":"2024-03-15","current":-26.009561,"twenty":-47.49129,"median":-35.24315,"eighty":-20.664708,"marketCap":2126463652},{"date":"2024-03-22","current":-25.786705,"twenty":-47.380514,"median":-34.925503,"eighty":-20.66947,"marketCap":2108243640},{"date":"2024-03-28","current":-24.935846,"twenty":-47.342533,"median":-34.589879,"eighty":-20.66947,"marketCap":2038679948},{"date":"2024-04-05","current":-25.071983,"twenty":-47.312176,"median":-34.414946,"eighty":-20.689994,"marketCap":2049810139},{"date":"2024-04-12","current":-25.888808,"twenty":-47.269427,"median":-33.423363,"eighty":-20.697474,"marketCap":2116591283},{"date":"2024-04-19","current":-23.631195,"twenty":-47.158961,"median":-33.184171,"eighty":-20.697474,"marketCap":1932015619},{"date":"2024-04-26","current":-22.916473,"twenty":-46.951231,"median":-33.003753,"eighty":-20.698257,"marketCap":1873582118},{"date":"2024-05-03","current":-23.897861,"twenty":-46.656905,"median":-32.649248,"eighty":-20.698257,"marketCap":1953817432},{"date":"2024-05-10","current":-23.114516,"twenty":-46.598159,"median":-32.247909,"eighty":-20.698257,"marketCap":1889773514},{"date":"2024-05-17","current":-24.517522,"twenty":-46.43348,"median":-31.759443,"eighty":-20.698257,"marketCap":2004479038},{"date":"2024-05-24","current":-22.904066,"twenty":-46.181838,"median":-31.451512,"eighty":-20.698257,"marketCap":1872567685},{"date":"2024-05-31","current":-20.986625,"twenty":-46.068748,"median":-31.128449,"eighty":-20.698257,"marketCap":1715803469},{"date":"2024-06-07","current":-20.224161,"twenty":-45.830813,"median":-30.643949,"eighty":-20.66395,"marketCap":1892880316},{"date":"2024-06-14","current":-21.429439,"twenty":-45.725202,"median":-30.31849,"eighty":-20.645029,"marketCap":2005688335},{"date":"2024-06-21","current":-21.357939,"twenty":-45.671397,"median":-29.967092,"eighty":-20.641966,"marketCap":1998996334},{"date":"2024-06-28","current":-23.247571,"twenty":-45.51108,"median":-29.932669,"eighty":-20.635726,"marketCap":2175856364},{"date":"2024-07-05","current":-22.542789,"twenty":-45.42729,"median":-29.794252,"eighty":-20.635726,"marketCap":2109892353},{"date":"2024-07-12","current":-21.439653,"twenty":-45.27192,"median":-29.668005,"eighty":-20.635726,"marketCap":2006644335},{"date":"2024-07-15","current":-21.807365,"twenty":-45.165128,"median":-29.6527,"eighty":-20.635726,"marketCap":2041060341},{"date":"2024-08-02","current":-20.438659,"twenty":-44.67116,"median":-29.473821,"eighty":-20.619869,"marketCap":1912956320},{"date":"2024-08-09","current":-18.937169,"twenty":-44.592228,"median":-29.326821,"eighty":-20.554877,"marketCap":1772424296},{"date":"2024-08-16","current":-19.846234,"twenty":-44.342086,"median":-29.065787,"eighty":-20.488395,"marketCap":1857508310},{"date":"2024-08-23","current":-19.366166,"twenty":-44.293477,"median":-28.968658,"eighty":-20.439367,"marketCap":1812576303},{"date":"2024-08-30","current":-20.193518,"twenty":-44.126836,"median":-28.878841,"eighty":-20.396729,"marketCap":1890012316},{"date":"2024-09-06","current":-20.851386,"twenty":-44.070828,"median":-28.815003,"eighty":-20.350301,"marketCap":1731811836},{"date":"2024-09-13","current":-19.495653,"twenty":-43.902513,"median":-28.750118,"eighty":-20.261779,"marketCap":1619211496},{"date":"2024-09-20","current":-20.358392,"twenty":-43.724824,"median":-28.493474,"eighty":-20.244564,"marketCap":1690866258},{"date":"2024-09-27","current":-20.324779,"twenty":-43.52784,"median":-28.425739,"eighty":-20.226358,"marketCap":1688074514},{"date":"2024-10-04","current":-19.753355,"twenty":-43.367535,"median":-28.373476,"eighty":-20.209123,"marketCap":1640614867},{"date":"2024-10-11","current":-20.30237,"twenty":-43.311657,"median":-28.264591,"eighty":-20.195561,"marketCap":1686213351},{"date":"2024-10-18","current":-21.030656,"twenty":-43.248031,"median":-28.136018,"eighty":-20.195561,"marketCap":1746701137},{"date":"2024-10-25","current":-20.078282,"twenty":-43.248031,"median":-28.049113,"eighty":-20.145499,"marketCap":1667601725},{"date":"2024-10-31","current":-20.649706,"twenty":-43.248031,"median":-27.765641,"eighty":-20.132647,"marketCap":1715061372},{"date":"2024-11-08","current":-22.688907,"twenty":-43.252213,"median":-27.636067,"eighty":-20.132233,"marketCap":1884427173},{"date":"2024-11-15","current":-21.960621,"twenty":-43.252213,"median":-27.448241,"eighty":-20.132233,"marketCap":1823939387},{"date":"2024-11-22","current":-22.229527,"twenty":-43.231304,"median":-27.106738,"eighty":-20.132233,"marketCap":1846273338},{"date":"2024-11-29","current":-25.707412,"twenty":-43.145724,"median":-26.876224,"eighty":-20.132233,"marketCap":1914893729},{"date":"2024-12-06","current":-25.40483,"twenty":-43.145724,"median":-26.625426,"eighty":-20.132233,"marketCap":1892354961},{"date":"2024-12-13","current":-24.521289,"twenty":-43.145724,"median":-26.466422,"eighty":-20.132233,"marketCap":1826541758},{"date":"2024-12-20","current":-22.572657,"twenty":-43.145724,"median":-26.327469,"eighty":-20.132233,"marketCap":1681392092},{"date":"2024-12-27","current":-22.173248,"twenty":-43.145724,"median":-26.203648,"eighty":-20.132233,"marketCap":1651640919},{"date":"2025-01-03","current":-21.785943,"twenty":-43.145724,"median":-26.12294,"eighty":-20.132233,"marketCap":1622791296},{"date":"2025-01-10","current":-21.434947,"twenty":-43.151859,"median":-25.994723,"eighty":-20.130744,"marketCap":1596646325},{"date":"2025-01-17","current":-22.584761,"twenty":-43.151859,"median":-25.832017,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-24","current":-22.584761,"twenty":-43.151859,"median":-25.722549,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-31","current":-22.330591,"twenty":-43.151859,"median":-25.688138,"eighty":-20.130744,"marketCap":1663361078},{"date":"2025-02-07","current":-23.032583,"twenty":-43.151859,"median":-25.544418,"eighty":-20.130744,"marketCap":1715651020},{"date":"2025-02-14","current":-23.601438,"twenty":-43.151859,"median":-25.410136,"eighty":-20.130744,"marketCap":1758023904},{"date":"2025-02-21","current":-22.149042,"twenty":-43.151859,"median":-25.353801,"eighty":-20.130744,"marketCap":1649837817},{"date":"2025-02-28","current":-21.229191,"twenty":-43.151859,"median":-25.248903,"eighty":-20.130744,"marketCap":1581319962},{"date":"2025-03-07","current":-20.902402,"twenty":-43.157994,"median":-25.114351,"eighty":-20.129255,"marketCap":1556978093},{"date":"2025-03-14","current":-25.841364,"twenty":-43.157994,"median":-25.015259,"eighty":-20.118618,"marketCap":1407320673},{"date":"2025-03-21","current":-31.526661,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1716941957},{"date":"2025-03-28","current":-31.810986,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1732426315},{"date":"2025-04-04","current":-28.415807,"twenty":-43.157994,"median":-25.140052,"eighty":-20.118618,"marketCap":1547524873},{"date":"2025-04-11","current":-25.672904,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1398146368},{"date":"2025-04-17","current":-25.238054,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1374464410},{"date":"2025-04-25","current":-26.22483,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1428204238},{"date":"2025-05-02","current":-26.007405,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1416363259},{"date":"2025-05-09","current":-26.208105,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1427293394},{"date":"2025-05-16","current":-28.064582,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1528397138},{"date":"2025-05-23","current":-26.826931,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1460994642},{"date":"2025-05-30","current":-40.212905,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1483896395},{"date":"2025-06-06","current":-38.417271,"twenty":-42.89345,"median":-25.054079,"eighty":-20.118618,"marketCap":1417635735},{"date":"2025-06-13","current":-37.443101,"twenty":-42.85482,"median":-25.054079,"eighty":-20.118618,"marketCap":1381687885},{"date":"2025-06-20","current":-35.644634,"twenty":-42.692819,"median":-25.045717,"eighty":-20.116377,"marketCap":1315322623},{"date":"2025-06-27","current":-37.218293,"twenty":-42.4845,"median":-25.045717,"eighty":-20.116377,"marketCap":1373392227},{"date":"2025-07-03","current":-39.940973,"twenty":-42.385562,"median":-25.045717,"eighty":-20.116377,"marketCap":1473861860},{"date":"2025-07-11","current":-39.516335,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1458192284},{"date":"2025-07-18","current":-36.593825,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1350348733},{"date":"2025-07-23","current":-36.568846,"twenty":-42.149407,"median":-25.045717,"eighty":-20.116377,"marketCap":1349426994}],"updateTime":1753419634511}}}